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gestational age
Abstract
ABSTRACT Aim: Intrauterine conditions may interfere with fetal brain development. We compared the
neurodevelopmental outcome between infants <32 weeks gestational age after maternal preeclampsia or
chorioamnionitis and controls. Methods: Case-control study on infants with maternal preeclampsia,
chorioamnionitis and controls (each n = 33) matched for gestational age. Neurodevelopment at two
years was assessed with the Bayley Scales of Infant Development II. Results: Ninety-nine infants were
included with a median gestational age of 29 weeks (range 25-32). Median mental developmental index
(MDI) was 96 in the control, 90 in the chorioamnionitis and 86 in the preeclampsia group. Preeclampsia
infants had a lower MDI compared with the control group (univariate p = 0.021, multivariate p = 0.183)
and with the chorioamnionitis group (univariate p = 0.242; multivariate p = 0.027). Median
psychomotor index was 80.5 in the control, 80 in the preeclampsia and 85 in the chorioamnionitis group,
and was not different between these three groups (p > 0.05). Chorioamnionitis or preeclampsia exposure
was not associated with major neurodevelopmental impairments (cerebral palsy, MDI<70, PDI<70).
Conclusion: The results of this preliminary study suggest that preeclampsia and chorioamnionitis play a
relatively minor role among risk factors for adverse neurodevelopment outcome. Postnatal factors such
as ventilation and bronchopulmonary dysplasia may have a greater impact on neurodevelopmental
outcome.
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ABSTRACT
Aim: Intrauterine conditions may interfere with foetal brain development. We com-
pared the neurodevelopmental outcome between infants <32 weeks gestational age after
maternal preeclampsia or chorioamnionitis and controls.
Methods: Case-control study on infants with maternal preeclampsia, chorioamnio-
nitis and controls (each n = 33) matched for gestational age. Neurodevelopment at
2 years was assessed with the Bayley Scales of Infant Development II.
Results: A total of 99 infants were included with a median gestational age of
29 weeks (range 25–32). Median mental developmental index (MDI) was 96 in the con-
trol, 90 in the chorioamnionitis and 86 in the preeclampsia group. Preeclampsia infants
had a lower MDI compared with the control group (univariate p = 0.021, multivariate
p = 0.183) and with the chorioamnionitis group (univariate p = 0.242; multivariate
p = 0.027). Median psychomotor index was 80.5 in the control, 80 in the preeclampsia
and 85 in the chorioamnionitis group and was not different between these three groups
(p > 0.05). Chorioamnionitis or preeclampsia exposure was not associated with major
neurodevelopmental impairments (cerebral palsy, MDI<70, PDI<70).
Conclusion: The results of this preliminary study suggest that preeclampsia and chorioamnionitis
play a relatively minor role among risk factors for adverse neurodevelopment outcome. Postnatal
factors such as ventilation and bronchopulmonary dysplasia may have a greater impact on neuro-
developmental outcome.
INTRODUCTION
Advances in perinatal care have lead to an improved
survival of very preterm infants over the last decade (1).
However, the prevalence of major neonatal and long-term
morbidities has not significantly changed (2) and a high
proportion of very preterm infants survive with long-term
neurodevelopmental impairments (3). Postnatal factors
such as intraventricular haemorrhage (IVH), ventilation
and bronchopulmonary dysplasia (BPD), inflammatory
conditions such as sepsis and necrotizing enterocolitis
(NEC) and poor postnatal growth have all been linked
to impaired neurodevelopmental outcome (4). The
developing premature brain is highly vulnerable to intra-
uterine and perinatal events (5). Maternal preeclampsia
and chorioamnionitis represent two distinct pathologies
often leading to premature birth. Both conditions may
harm the foetal brain: maternal preeclampsia interferes
with placental blood supply and leads to chronic intrauter-
ine hypoxia that may reduce foetal brain growth and can
cause ischaemic brain damage (6). Chorioamnionitis
exposes the immature brain to high levels of circulating
cytokines that have been associated with neuronal apopto-
sis. This may lead to periventricular leucomalacia with
major neurological sequelae (5). Currently available infor-
mation on the neurodevelopmental outcome in very
preterm infants exposed to preeclampsia and chorioamnio-
nitis is limited, and no study has compared these two
groups so far. Thus, the aim of this study was to investigate
whether neurodevelopmental outcome assessed at 2 years
of age differs between very preterm infants exposed to
preeclampsia, chorioamnionitis and controls.
Abbreviations
BPD, bronchopulmonary dysplasia; IVH, intraventricular
haemorrhage; MDI, mental developmental index; NEC,
necrotizing enterocolitis; PDA, persistent ductus arteriosus; PDI,
psychomotor developmental index.
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PATIENTS AND METHODS
Between 2002 and 2005, 571 preterm infants were born at
25–32 completed weeks of gestation at the University Hos-
pital Zurich, 492 of these survived the first hospitalization
period. Infants were excluded (n = 372) if they were born
from a twin or higher gestation, or if they suffered from
other major conditions that may independently affect
neurodevelopmental outcome such as hypoxic-ischaemic
encephalopathy, congenital malformations or chromosomal
defects. To avoid overlap between preeclampsia and chorio-
amnionitis, infants exposed simultaneously to both pre-
eclampsia and chorioamnionitis were excluded. Only
infants who underwent a neurodevelopmental assessment
with the Bayley Scales of Infant Development II (BSID-II)
were included (n = 106) .
Three groups of infants were defined (7): i) infants
exposed to maternal preeclampsia; ii) infants exposed to
maternal chorioamnionitis; and iii) control infants. The
three groups were matched for gestational age, leaving 33
infants in each group. Preeclampsia was diagnosed using
the National Institutes of Health clinical criteria (protein-
uria >300 mg ⁄d and diastolic blood pressure >90 mmHg in
two measurements ‡ 4 h apart occurring after the 20th
week of pregnancy and regressing after delivery) and ⁄or
acute spiral artery atherosis on placental histology or
placental bed biopsy (6). Chorioamnionitis was diagnosed
by the combination of maternal fever, elevated maternal
C-reactive protein, foetal tachycardia and chorioamnionitis
on placental histology. The control group included preterm
births associated with other known or uncharacterized
maternal aetiology (such as premature detachment of the
placenta; placenta praevia; growth retardation; pathological
cardiotocography; failed tocolysis).
Clinical characteristics and baseline data were extracted
from the institutional neonatal database. Z-scores for
weight percentiles were calculated at birth based on the
growth curves by Voigt et al. (8) and at 2 years of age based
on the Swiss growth curves (9). NEC was defined as Bell’s
stage II or higher. Significant IVH was defined as grade 3 or
higher bleeding according to the classification of Papile.
Sepsis was defined as the recovery of clinically relevant bac-
terial pathogens from at least one blood culture. BPD was
defined as requirement for additional oxygen at 36 weeks
gestational age.
Neurodevelopmental examination was performed rou-
tinely by experienced developmental paediatricians at
2 years corrected age at the Child Development Centre of
the University Children’s Hospital Zurich, Switzerland.
Adverse neurodevelopmental outcome was defined as
cerebral palsy (CP) and ⁄or mental developmental index
(MDI) and/or Psychomotor Developmental Index (PDI)
less than 70 (>2 SDS below the mean of 100). Cerebral
palsy was defined as a non-progressive disorder character-
ized by abnormal tone in at least one extremity and
abnormal control of movement and posture. Infants who
were so severely impaired that a structured testing with
the BSID-II was not feasible were assigned an MDI or
PDI score of 49; this was the case for three children, two
of whom were diagnosed with CP, the other with mental
retardation alone.
STATISTICS
The Mann–Whitney U-test and Spearman rank sum test
were used for non-normally distributed variables. Associa-
tions between neonatal variables as well as preeclampsia or
chorioamnionitis status and MDI and PDI were analysed
using uni- and multivariate linear regression. Association
with adverse neurological outcome (cerebral palsy, MDI
<70, PDI <70) was analysed using uni- andmultivariate binary
logistic regression and expressed as odds ratio and confidence
intervals. Multivariate analyses included study group (control,
preeclampsia or chorioamnionitis), gestational age, birth
weight, body weight at 2 years, BPD and mechanical venti-
lation as covariates. Two-sided tests were used throughout,
and a p-value below 0.025 was considered significant. SPSS
17.0 software (SPSS Inc., Chicago, USA) was used.
The study was designed in accordance with the Helsinki
declaration and with approval for retrospective studies by
the ethical commission of the University Children’s Hospi-
tal of Zurich.
RESULTS
Baseline characteristics
A total of 99 infants were included, each 33 in the pre-
eclampsia, the chorioamnionitis and the control group.
Baseline demographic characteristics of the three groups
are summarized in Table 1. Infants in the preeclampsia
group were significantly more often delivered by Caesarean
section, had lower birth weight and required more often
mechanical ventilation compared with the chorioamnioni-
tis and the control group. No significant difference was
found among the three groups regarding postnatal risk fac-
tors such as IVH > grade 2, retinopathy of prematurity,
NEC or sepsis.
Association with MDI and PDI
Neurodevelopmental outcome was assessed at a median of
23 months corrected age (interquartile range, IQR, 14–
25 months). Age at neurodevelopmental examination was
not significantly different between the three groups. When
analysing MDI and PDI outcome for all 99 infants, median
MDI was 90 (82–100) and median PDI 84 (IQR 70–93).
Gestational age and postnatal growth (weight Z-scores at
2 years) were significantly associated with MDI (p = 0.037
and 0.001, respectively), while mechanical ventilation and
BPD were significantly associated with PDI (p = 0.001 and
0.035, respectively). Decreasing birth weight (by SDS)
showed a trend for lower MDI and PDI. These factors were
thus included in the multivariate analysis.
MedianMDI scores were 96 in the control group, 90 in the
chorioamnionitis group and 86 in the preeclampsia group
(Fig. 1). The preeclampsia group had significantly lower
MDI scores compared with the control group (Mann–Whit-
ney U-test: preeclampsia vs control: Z )2.304, p = 0.021;
Schlapbach et al. Chorioamnionitis, preeclampsia and neurodevelopment
ª2010 The Author(s)/Journal Compilation ª2010 Foundation Acta Pædiatrica/Acta Pædiatrica 2010 99, pp. 1504–1509 1505
chorioamnionitis vs control: Z )1.104, p = 0.270; chorioam-
nionitis vs preeclampsia: Z )1.169, p = 0.242).
In the multivariate analysis adjusted for gestational age,
birth weight, postnatal growth, mechanical ventilation and
BPD, preeclampsia infants had lower MDI scores com-
pared with chorioamnionitis infants (p = 0.027), while the
difference between preeclampsia and controls infants was
not significant (p = 0.183) anymore. No significant differ-
ence was found between chorioamnionitis and control
infants for MDI.
Median PDI scores were 80.5 in the control group, 80 in
the preeclampsia group and 85 in the chorioamnionitis
group (Fig. 1). PDI scores were not significantly different
between the three groups in univariate analysis (Mann–
Whitney U-test; preeclampsia vs control: Z )0.092,
p = 0.927; chorioamnionitis vs control: Z )0.604, p = 0.546;
chorioamnionitis vs preeclampsia: Z )0.494, p = 0.621).
This was confirmed using multivariate analysis (p > 0.05,
details not shown).
Association with adverse neurodevelopmental outcome
One child in each the chorioamnionitis and the control
group and three children in the preeclampsia group were
diagnosed with cerebral palsy. As a result of the small sam-
ple size, this outcome was not analysed separately. Adverse
neurodevelopmental outcome was defined as the presence
of cerebral palsy and ⁄or MDI score <70 and ⁄or PDI score
<70. Adverse neurodevelopmental outcome occurred in
10 ⁄33 infants in the control group and in 8 ⁄33 in the cho-
rioamnionitis and in 8 ⁄33 in the preeclampsia group. Uni-
variate binary logistic regression showed no significant
differences for adverse neurodevelopmental outcome when
comparing the chorioamnionitis, preeclampsia and control
group (preeclampsia vs control: OR 1.36, p = 0.58, CI 0.46–
4.04; chorioamnionitis vs control: OR 1.36, p = 0.581, CI
0.46–4.04; chorioamnionitis vs preeclampsia: OR 1.00,
p = 1.000, CI )0.32–3.08). Multivariate analysis confirmed
that the risk of adverse neurodevelopmental outcome was
not significantly different between the chorioamnionitis,
preeclampsia and control group (p > 0.05; details not
shown). Adverse neurodevelopmental outcome was signifi-
cantly associated with mechanical ventilation (OR 2.96, CI
1.18–7.45, p = 0.021), BPD (OR 3.75, CI 1.08–11.14,
p = 0.036) and poor postnatal growth (OR 1.92, CI 1.27–
2.91, p = 0.002), while sepsis and lower birth weight
showed a trend towards significance (p = 0.055 and 0.053,
respectively). Additional analyses including gender in the
multivariate analysis did not significantly alter the results.
DISCUSSION
The results of this study indicate that maternal preeclampsia
and chorioamnionitis have a relatively minor impact on
neurodevelopmental outcome of very preterm infants.
While we found lower MDI scores in infants of preeclamp-
tic mothers compared with controls and chorioamnionitis
infants, this finding was not significant in the multivariate
analysis. Adverse neurological outcome did not differ
between the chorioamnionitis, preeclampsia and the con-
trol group. Postnatal factors such as BPD, postnatal growth
and sepsis affected outcome more than maternal chorio-
amnionitis or preeclampsia.
Table 1 Demographic and medical variables stratified for group
Chorioamnionitis (n = 33) Preeclampsia (n = 33) Controls (n = 33)
N (%) Median (range) N (%) Median (range) N (%) Median (range)
Gender (male) 19 (58%) 13 (39%) 17 (52%)
Apgar 5 min 8 (3–10) 8 (4–10) 8 (5–9)
Apgar 10 min 9 (3–10) 9 (6–10) 8 (6–10)
Prenatal steroids 27 (82%) 25 (76%) 30 (91%)
Caesarean section 14 (42%)* 25 (76%)ƒ* 14 (42%)ƒ
Gestational age (weeks) 28.6 (25.1–32) 29.9 (26.6–32) 30 (25.7–31.7)
Birth weight [gram] 1300 (650–1880) 980 (610–1700)ƒ 1280 (610–1850)ƒ
Birth weight SDS )0.07 ()2.13–1.35)* )1.36 ()2.44–0.52)ƒ* )0.13 ()3.82–1.11)ƒ
Head circumference [cm] 26.5 (22–32) 26 (23–30) 27 (22–32)
Cord blood arterial pH 7.35 (7.18–7.45)* 7.31 (7.13–7.42)* 7.34 (7.11–7.41)
IVH>2 2 (6%) 2 (6%) 1 (3%)
ROP>2 2 (6%) 2 (6%) 4 (12%)
NEC 3 (9%) 3 (9%) 4 (12%)
PDA 8 (24%) 15 (46%) 11 (33%)
Sepsis 3 (9%) 5 (15%) 4 (12%)
Mechanical ventilation 11 (33%)* 19 (58%)ƒ* 8 (24%)ƒ
Duration of mechanical ventilation 0 (0–14)* 1 (0–9)ƒ* 0 (0–5)ƒ
BPD 3 (9%) 5 (15%) 6 (18%)
Mann–Whitney U-test:
ƒDifference significant between preeclampsia and control group; p < 0.05
*Difference significant between chorioamnionitis and preeclampsia group; 0 < 0.05
BPD, bronchopulmonary dysplasia; IVH, intraventricular haemorrhage; NEC, necrotizing enterocolitis; PDA, persistent ductus arteriosus; ROP, retinopathy of
prematurity.
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Infants in the preeclampsia group scored on average ten
MDI scores lower than infants in the control group. After
adjustment for several confounders, Preeclampsia infants
had significantly lower MDI scores compared with chorio-
amnionitis infants, while the difference between preeclamp-
sia and control infants was weaker. No difference regarding
PDI scores was found between the three groups. Gray et al.
postulated a protective effect of maternal hypertension
against cerebral palsy (10), while a later study reported
mildly delayed MDI at 24 months in preeclampsia infants
(11). The recent study by Silveira et al. found higher PDI
scores in preeclampsia infants (12). Preeclampsia is not a
uniform disease and may range from a subacute or chronic
course to acute maternal disease with sudden deterioration
preeclampsia placentofetal blood supply (6). Although the
haemodynamic effects of preeclampsia probably can be
partly reduced by foetal compensatory mechanisms, even
moderate preeclampsia exposes the foetus to placental
insufficiency with consequent intrauterine growth failure.
As postnatal growth has an independent effect on neurode-
velopment, as shown by Casey et al. (13) and Latal et al.
(14), we controlled for postnatal growth when analysing the
effect of preeclampsia on outcome. Antenatal maternal
treatment with magnesium sulphate may improve the
neurodevelopmental outcome of premature infants (15).
However, as mothers with risk pregnancies are routinely
supplemented with magnesium sulphate at our centre, we
could not assess to what extend this affected outcome.
In contrast to the common belief that chorioamnionitis is
a risk factor for poor outcome, MDI and PDI scores were
not different between infants in the chorioamnionitis and
the control group in this study, but the study may be under-
powered to detect smaller differences in outcomes. While
chorioamnionitis has been shown to be associated with a
significant increase in cerebral palsy in the meta-analysis by
Wu et al. (5), the association with moderately reduced neu-
rodevelopmental outcome is much less clear (4). Higher
rates of chorioamnionitis were found among mothers of
neurologically impaired very preterm children when
compared with controls in an earlier study (16). There is
evidence supporting the link between severe chorioamnio-
nitis and periventricular leucomalacia (4), however, which
affects only 3–4% of all very preterm infants. Notably, cho-
rioamnionitis represents a spectrum from severe foetal
inflammatory response syndrome with funisitis to a mild
mainly maternal disease with little effect on the foetus (17),
a fact that may partly account for the inconsistent results in
previous studies on chorioamnionitis.
The lack of conclusive results on the effect of preeclamp-
sia and chorioamnionitis on neurodevelopmental outcome
currently offers little guidance to obstetric management of
mothers with chorioamnionitis or preeclampsia who need
to weigh the risk of preterm birth vs the risk of prolonged
foetal exposure to chorioamnionitis or preeclampsia. If
maternal chorioamnionitis or preeclampsia affect outcome,
this may even influence decisions to initiate, continue or
withdraw intensive care support in extremely premature
newborns at the limit of viability. To date, information on
preeclampsia and chorioamnionitis are largely inconclusive
to support such decisions.
Several postnatal variables such as mechanical ventila-
tion, BPD and postnatal growth failure were significantly
associated with decreased MDI and PDI scores and with
adverse neurological outcome, suggesting that postnatal dis-
ease may do more harm to the immature brain compared
with chorioamnionitis and preeclampsia. Bronchopulmo-
nary dysplasia, brain injury as visible on ultrasound, severe
retinopathy of prematurity and neonatal infection were
shown to predict poor outcome at 18 months in extremely
preterm infants with surprisingly high accuracy (18,19).
Major IVH occurred in 5% of all children in our cohort and
was not associated with adverse outcome in the univariate
analysis; we thus did not include IVH as a covariable in the
multivariate analyses. Recent improvements in magnetic
resonance imaging such as diffusion tensor imaging have
allowed to identify specific white matter abnormalities in
premature infants that probably reflect the anatomic sub-
strate of poor neurodevelopmental outcome in these high-
risk babies (20). Anjari et al. reported that white matter
abnormalities are present at term in very preterm infants
that had required mechanical ventilation (20). Two recent
imaging studies could not show an association between
Figure 1 Mental development index (MDI) and psychomotor development
index (PDI) are given for infants in the chorioamnionitis (CA), preeclampsia
(PE) and control group. The medians are shown.
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histopathological chorioamnionitis and PVL or brain vol-
ume (21) and non-cystic white matter injury (22). In the lat-
ter study, also no effect of chorioamnionitis on brain
metabolism or brain microstructure was found. However,
postnatal hypotension was associated with white matter
injury.
Strengths of this study include the comparison of pre-
eclampsia, chorioamnionitis and a control group, while
other studies focussed solely on preeclampsia or chorioam-
nionitis infants (10,16,23). Infants were matched for gesta-
tional age. In addition, definition of preeclampsia and
chorioamnionitis required presence of both clinical and pla-
centahistological criteria, thus avoiding overlap of these
entities. The statistical analysis adjusted for several impor-
tant confounders such as ventilation, BPD, gestational age,
birth weight and postnatal growth. Several limitations of
this study need to be addressed. Firstly, the relatively small
sample size limits the statistical power, a limitation, how-
ever, that applies also to several other studies (10,16,23).
Secondly, the age range at the follow-up examination was
relatively wide, but results from the Bayley Scales of Infant
Development are expressed as age-related values and there-
fore become age-independent. It is known, however, that
assessing neurodevelopmental outcome at 2 years of age
may underestimate the full spectrum of cognitive and neu-
romotor functions (24,25). Thus, long-term outcome such
as specific learning difficulties or milder motor dysfunctions
may still be associated with these conditions.
In conclusion, the results of this preliminary study suggest
that chorioamnionitis and preeclampsia have a relatively
minor impact on long-term neurodevelopmental outcome
in very preterm infants. Although placental insufficiency
caused by maternal preeclampsia may reduce performance
at 2 years of age, this was not associated with an increase of
severe disabilities, but this study may be underpowered to
detect such differences. By contrast, well-described postna-
tal risk factors such as mechanical ventilation, BPD, postnatal
growth failure and sepsis affected long-term development
much stronger. Larger prospective trials are urgently needed
to improve our understanding of long-term outcome in
infants exposed to chorioamnionitis or preeclampsia.
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